Animal metrics: Tracking contributions of new approach methods to reduced animal use

Main Article Content

Sue Marty
Amanda Andrus
Katherine Groff

Abstract

Many companies and global regulatory programs have expressed the intent to move away from in vivo animal testing to new approach methods (NAMs) as part of product safety assessments. NAMs, which include non-animal approaches for testing and assessment - from computer-based modeling to in chemico or in vitro models, allow faster data generation with potentially greater relevance to humans while avoiding animal use. To monitor progress implementing NAMs, each organization first must define what is in scope, starting with the definition of ‘animal’ (e.g., mammals, vertebrates) and applicable studies (e.g., animals used for ‘in house’ experiments, at contract research organizations, as part of environmental monitoring). Next, organizations must establish baseline animal use, including defined rules for inclusion/exclusion of animals that ensure consistency in future assessments. Lastly, organizations must establish metrics for animal savings based on the utility of NAM data. This paper presents one approach to establish ‘animal use’ metrics in a toxicology program at The Dow Chemical Company. The premise of our program is that most NAM information has value for animal savings, but the value depends on how data are used (e.g., research and development, screening, or regulatory requirements) and level of certainty for internal decision making. This manuscript provides metrics on the impact of NAMs, allowing a quantitative assessment of animal use numbers over time, accountability for resources spent on NAM development, and identification of areas where NAM development is still needed. This approach can be refined for use at other organizations.

Article Details

How to Cite
Marty, S., Andrus, A. and Groff, K. (2021) “Animal metrics: Tracking contributions of new approach methods to reduced animal use ”, ALTEX - Alternatives to animal experimentation. doi: 10.14573/altex.2107211.
Section
Articles
References

Archibald, K., Drake T., and Coleman, R. (2015). Barriers to the uptake of human-based test methods, and how to overcome them. Altern Lab Anim 43, 301–308. doi:10.1177/026119291504300504

Ball, N., Cronin M. T. D., Shen J. et al. (2016). Toward good read-across practice (GRAP) guidance. ALTEX 33, 149-166. doi:10.14573/altex.1601251

Baltazar, M. T., Cable, S., Carmichael, P. L. et al. (2020). A next-generation risk assessment case study for coumarin in cosmetic products. Toxicol Sci 176, 236-252. doi:10.1093/toxsci/kfaa048

Bhhatarai, B., Wilson, D. M., Bartels, M. J. et al. (2015). Acute toxicity prediction in multiple species by leveraging mechanistic ToxCast mitochondrial inhibition data and simulation of oral bioavailability. Toxicol Sci 147, 386-396. doi:10.1093/toxsci/kfv135

Chary, A., Hennen, J., Klein, S. G. et al. (2018). Respiratory sensitization: toxicological point of view on the available assays. Arch Toxicol 92, 803-822. doi:10.1007/s00204-017-2088-5

Chary, A., Serchi, T., Moschini, E. et al. (2019). An in vitro coculture system for the detection of sensitization following aerosol exposure. ALTEX 36, 403-418. doi:10.14573/altex.1901241

Clippinger, A. J., Hill, E., Curren, R., and Bishop P. (2016). Bridging the gap between regulatory acceptance and industry use of non-animal methods. ALTEX 33, 453-458. doi:10.14573/altex.1601311

Clippinger, A. J., Raabe, H. A., Allen, D. G. et al. (2021). Human-Relevant Approaches to Assess Eye Corrosion/Irritation Potential of Agrochemical Formulations. Cutan Ocul Toxicol 40, 145-167. doi:10.1080/15569527.2021.1910291

Corvaro, M., Gehen, S., Andrews, K. et al. (2016). GHS additivity formula: A true replacement method for acute systemic toxicity testing of agrochemical formulations. Regul Toxicol Pharmacol 82, 99-110. doi:10.1016/j.yrtph.2016.10.007

Dalvie, D., Obach, R. S., Kang, P. et al. (2009). Assessment of three human In vitro systems in the generation of major human excretory and circulating metabolites. Chem Res Toxicol 22, 357-368. doi:10.1021/tx8004357

EC - European Commission (2020). Report from the Commission to the European Parliament and the Council. 2019 report on the statistics on the use of animals for scientific purposes in the Member States of the European Union in 2015-2017. European Commission, Brussels 5.2.2020. Report: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:52020DC0016&from=EN Website: https://ec.europa.eu/environment/chemicals/lab_animals/reports_en.htm (accessed 17 July 2021)

EFSA – European Food Safety Authority. (2014). Modern methodologies and tools for human hazard assessment of chemicals. Scientific report of EFSA. (87 pp.). EFSA J 12, 3638. doi:10.2903/j.efsa.2014.3638

EU – European Union (2009). Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products. European Union (EU). https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02009R1223-20190813&from=EN#tocId2 (accessed 17 July 2021).

EU – European Union (2010). Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ L 276, 33-79. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32010L0063&from=EN (accessed 17 July 2021).

EURL ECVAM - EU Reference Laboratory for alternatives to animal testing (2020). EURL ECVAM recommendation on non-animal-derived antibodies. (2020). doi:10.2760/80554

Groff, K., Allen, D., Casey, W., and Clippinger, A. J. (2020). Increasing the use of animal-free recombinant antibodies. ALTEX 37, 309-311. doi:10.14573/altex.2001071

ICCVAM – Interagency Coordinating Committee on the Validation of Alternative Methods (2018). A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States. https://ntp.niehs.nih.gov/whatwestudy/niceatm/natl-strategy/index.html (accessed 17 July 2021)

ICCVAM – Interagency Coordinating Committee on the Validation of Alternative Methods (2021). ICCVAM Metrics Workgroup. Measuring U.S. Federal Agency Progress Toward Implementation of Alternative Methods in Toxicity Testing. https://ntp.niehs.nih.gov/iccvam/docs/about_docs/iccvam-measuringprogress-feb2021-fd-508.pdf (accessed 17 July 2021).

Kleinstreuer, N. C., Hoffmann, S., Alépée, N. et al. (2018). Non-animal methods to predict skin sensitization (II): an assessment of defined approaches*. Crit Rev Toxicol 48, 359-374. doi:10.1080/10408444.2018.1429386

Krebs, A., van Vugt-Lussenburg, B. M. A., Waldmann, T. et al. (2020). The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods. Arch Toxicol 94, 2435-2461. doi:10.1007/s00204-020-02802-6

Krieger, S., Auernhammer, T., Hotchkiss, J., and Wilson, D. (submitted). Mechanistic profiling of inhalation sensory irritants with a computational model for transient receptor potential vanilloid subfamily type 1 (TRPV1). Applied In Vitro Toxicol

Ladics, G. S., Smith, C., Heaps, K. et al. (1995). Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 96, 225–38. doi:10.1016/0300-483x(94)02967-y

Leist, M., Efremova, L., and Karreman, C. (2010). Food for thought considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309–317. doi:10.14573/altex.2010.4.309

Luechtefeld, T., Maertens, A., Russo, D. P., et al. (2016). Analysis of Draize eye irritation testing and its prediction by mining publicly available 2008-2014 REACH data. ALTEX 33, 123-134. doi:10.14573/altex.1510053

Luechtefeld, T., Marsh, D., Rowlands, C., and Hartung, T. (2018). Machine learning of toxicological big data enables read-across structure activity relationships (RASAR) outperforming animal test reproducibility. Toxicol Sci 165, 198-212. doi:10.1093/toxsci/kfy152

Lillicrap, A., Belanger, S., Burden, N. et al. (2016). Alternative approaches to vertebrate ecotoxicity tests in the 21st century: a review of developments over the last 2 decades and current status. Environ Toxicol Chem 35, 2637-2646. doi:10.1002/etc.3603

Luccio-Camelo, D. C., and Prins, G. S. (2011). Disruption of androgen receptor signaling in males by environmental chemicals. J Steroid Biochem Mol Biol 127, 74-82. doi:10.1016/j.jsbmb.2011.04.004

Manolis, E., Vamvakas, S., and Isaac, M. (2011). New pathway for qualification of novel methodologies in the European Medicines Agency. Proteomics Clin Appl 5, 248-255. doi:10.1002/prca.201000130

Mansouri, K., Kleinstreuer, N., Abdelaziz, A. M. et al. (2020). COMPARA: collaborative modeling project for androgen receptor activity. Environ Health Perspect 128, 27002. doi:10.1289/EHP5580

Meigs, L., Smirnova, L., Rovida, C. et al. (2018). Animal testing and its alternatives–The most important omics is economics. ALTEX 35, 275-305. doi:10.14573/altex.1807041

NIH – National Institutes of Health (2015). Guidelines for preparing USDA annual reports and assigning USDA reporting columns. https://oacu.oir.nih.gov/sites/default/files/uploads/arac-guidelines/usda.pdf (accessed 17 July 2021).

NRC – National Research Council (2007). National Research Council. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: The National Academies Press. doi:10.17226/11970

OECD - Organisation for Economic Cooperation and Development (2009). Hershberger bioassay in rats: A short-term screening assay for (anti)androgenic properties. OECD Guideline for the Testing of Chemicals No. 441, OECD, Paris, France. doi:10.1787/20745788

OECD - Organisation for Economic Cooperation and Development (2010). Skin sensitization: Local lymph node assay. OECD Guideline for the Testing of Chemicals No. 429, OECD, Paris, France. doi:10.1787/20745788

OECD - Organisation for Economic Cooperation and Development (2015). Adverse Outcome Pathways, Molecular Screening and Toxicogenomics. OECD Testing of Chemicals, OECD, Paris, France.https://www.oecd.org/chemicalsafety/testing/adverse-outcome-pathways-molecular-screening-and-toxicogenomics.htm (accessed 17 July 2021).

OECD - Organisation for Economic Cooperation and Development (2016). Integrated approaches to testing and assessment (IATA). OECD Assessment of Chemicals, OECD, Paris, France. http://www.oecd.org/chemicalsafety/risk-assessment/iata-integrated-approaches-to-testing-and-assessment.htm (accessed 17 July 2021).

OECD - Organisation for Economic Cooperation and Development (2017). Guidance document on the reporting of defined approaches and individual information sources to be used within integrated approaches to testing and assessment (IATA) for skin sensitization. No. 256. OECD Series on Testing and Assessment, OECD, Paris, France. doi:10.1787/9789264279285-en

OECD - Organisation for Economic Cooperation and Development (2018a). Extended one-generation reproductive toxicity study. OECD Guideline for the Testing of Chemicals No. 443, OECD, Paris, France. doi:10.1787/20745788

OECD - Organisation for Economic Cooperation and Development (2018b). Guidance document on good in vitro methods practices (GIVIMP). No. 286. OECD Series on Testing and Assessment, OECD, Paris, France. doi:10.1787/20777876

OECD - Organisation for Economic Cooperation and Development (2021). Defined approaches on skin sensitization. OECD Guideline for the Testing of Chemicals No. 497, OECD, Paris, France. doi:10.1787/20745788

Pham, L. L., Watford S. M., Pradeep P. et al. (2020). Variability in in vivo studies: Defining the upper limit of performance for predictions of systemic effect levels. Comput Toxicol. 15, 100126. doi:10.1016/j.comtox.2020.100126

Rooney, J. P., Choksi, N. Y., Ceger, P. et al. (2021). Analysis of variability in the rabbit skin irritation assay. Regul Toxicol Pharmacol 122, 104920. DOI:doi:10.1016/j.yrtph.2021.104920

Rovida, C., and Hartung, T. (2009). Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals – a report by the Transatlantic Think Tank for Toxicology (t4). ALTEX 26, 187-208. doi:10.14573/altex.2009.3.187

Schmidt, B. Z., Lehmann, M., Gutbier, S. et al. (2017). In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Arch Toxicol 91, 1–33. doi:10.1007/s00204-016-1805-9

Terry, C., Rasoulpour, R. J., Saghir, S. et al. (2014). Application of a novel integrated toxicity testing strategy incorporating “3R” principles of animal research to evaluate the safety of a new agrochemical sulfoxaflor. Crit Rev Toxicol 44, 1-14. doi:10.3109/10408444.2014.910753

US EPA – US Environmental Protection Agency (2018). United States Environmental Protection Agency. Strategic Plan to Promote the Development and Implementation of Alternative Test Methods Within the TSCA Program. June 22, 2018. Available at https://www.epa.gov/sites/production/files/2018-06/documents/epa_alt_strat_plan_6-20-18_clean_final.pdf (accessed 17 July 2021).

US EPA – US Environmental Protection Agency (2019a). United States Environmental Protection Agency. Administrator memo prioritizing efforts to reduce animal testing, September 10, 2019. Available at: https://www.epa.gov/newsreleases/administrator-wheeler-signs-memo-reduce-animal-testing-awards-425-million-advance (accessed 26 September 2021).

US EPA – US Environmental Protection Agency (2019b). United States Environmental Protection Agency. Administrator memo prioritizing efforts to reduce animal testing, September 10, 2019. Available at: https://www.epa.gov/research/administrator-memo-prioritizing-efforts-reduce-animal-testing-september-10-2019 (accessed 17 July 2021).

US GAO – US Government Accountability Office (2019). Animal Use in Research: Federal Agencies Should Assess and Report on Their Efforts to Develop and Promote Alternatives. GAO-19-629 Available: https://www.gao.gov/products/gao-19-629 (accessed 17 July 2021).

Van der Laan, J. W., Chapin, R. E., Haenen, B. et al. (2012). Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches. Regul Toxicol Pharmacol 63, 115-123. doi:10.1016/j.yrtph.2012.03.009

Van der Valk, J., Mellor, D., Brands, R. et al. (2004). The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 18, 1-12. doi:10.1016/j.tiv.2003.08.009

Van der Valk, J., Brunner, D., De Smet, K. et al. (2010). Optimization of chemically defined cell culture media – replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24, 1053-1063. doi:10.1016/j.tiv.2010.03.016.

Van der Valk, J., Bieback, K., Buta, C. et al. (2018). Fetal Bovine Serum (FBS): Past – present – future. ALTEX 35, 99-118. doi:10.14573/altex.1705101

Wilson, D., Wijeyesakere, S. J., Parks, A. K. et al. (2018). Profiling acute oral and inhalation toxicity data using a computational workflow to screen for facile chemical reactivity. Appl In Vitro Toxicol 4, 214-219. doi:10.1089/aivt.2017.0041

Wijeyesakere, S., Wilson, D., Settivari, R. et al. (2018). Development of a profiler for facile chemical reactivity using the open-source Konstanz Information Miner. Appl In Vitro Toxicol 4, 202-213. doi:10.1089/aivt.2017.0040

Wijeyesakere, S. J., Wilson, D., Auernhammer, T. et al. (2019). Hybrid machine-learning/SMARTS profiling model for mitochondrial inhibition. Appl In Vitro Toxicol 5, 196-204. doi:10.1089/aivt.2019.0010

Wijeyesakere, S. J., Wilson, D. M., and Marty, M. S. (2020). Prediction of cholinergic compounds by machine learning. Computational Toxicology Vol. 13, doi:10.1016/j.comtox.2020.100119

Zhang, F., Bartels, M., Clark, A. et al. (2018). Performance evaluation of the GastroPlus™ software tool for prediction of the toxicokinetic parameters of chemicals. SAR QSAR Environ. Res 29, 875-893. doi:10.1080/1062936X.2018.1518928

Most read articles by the same author(s)